<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01374594</url>
  </required_header>
  <id_info>
    <org_study_id>GAL-INK II</org_study_id>
    <nct_id>NCT01374594</nct_id>
  </id_info>
  <brief_title>Importance of Meal Fat Content and Gall Bladder Emptying for Postprandial GLP-1 Secretion in Type 2 Diabetes Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Gentofte, Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      PURPOSE

      The goal of the present project is to unravel the importance of bile acid-induced GLP-1
      secretion (via the G protein-coupled receptor TGR5) in human physiology.

      In the present study the investigators examine the GLP-1 secretion in healthy subjects and in
      Type 2 Diabetes Mellitus (T2DM) patients. The investigators hypothesize that patients with
      T2DM of relatively long duration will be characterized by reduced gall bladder emptying, and,
      consequently, reduced intestinal TGR5 activation; resulting in attenuated postprandial GLP-1
      responses (primary endpoint).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2011</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>GLP-1 secretion</measure>
    <time_frame>Postprandial</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Healthy adults</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 2 diabetes</arm_group_label>
  </arm_group>
  <biospec_descr>
    <textblock>
      blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy subjects and type 2 diabetes patients (T2DM)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria: (Healthy)

          -  HbA1 &lt; 6 %

          -  Normal haemoglobin levels

          -  Informed content

        Inclusion Criteria: (T2DM)

          -  T2DM &gt; 5 years

          -  Normal haemoglobin levels

          -  Informed content

        Exclusion Criteria: (T2DM)

          -  Treatment with insulin, DPP-IV inhibitor or GLP-1 analogues

          -  Obesity (BMI &gt; 30)

          -  Age &gt; 70 years

          -  Gastrointestinal disease

          -  Nephropathy

          -  Liver disease

          -  Medication which cannot be on hold for 12h

          -  Gastrointestinal surgery

        Exclusion Criteria: (Healthy)

          -  1st degree relatives with diabetes

          -  Obesity (BMI &gt; 30)

          -  Age &gt; 70 years

          -  Gastrointestinal disease

          -  Nephropathy

          -  Liver disease

          -  Medication which cannot be on hold for 12h

          -  Gastrointestinal surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Gentofte University Hospital</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 14, 2011</study_first_submitted>
  <study_first_submitted_qc>June 15, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 16, 2011</study_first_posted>
  <last_update_submitted>January 22, 2013</last_update_submitted>
  <last_update_submitted_qc>January 22, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Gentofte, Copenhagen</investigator_affiliation>
    <investigator_full_name>David P. Sonne</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

